Literature DB >> 11602243

An amino acid residue whose change by mutation affects drug binding to the HERG channel.

K Ishii1, K Kondo, M Takahashi, M Kimura, M Endoh.   

Abstract

We did the experiments to search for amino acids that affect quinidine binding to the HERG channel, and have identified an amino acid whose change by mutation affects the binding of various drugs. The residue is located at position 647 in the S6 and is not involved in the recently identified methanesulfonanilide binding pocket. The homology model of the HERG channel indicated that the residue faces toward the outside of the channel pore. We conclude that the residue at position 647 does not interact directly with drug molecules but plays an important role in keeping the binding site's high affinity for drugs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11602243     DOI: 10.1016/s0014-5793(01)02902-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

1.  Inhibition of the current of heterologously expressed HERG potassium channels by flecainide and comparison with quinidine, propafenone and lignocaine.

Authors:  Ashok A Paul; Harry J Witchel; Jules C Hancox
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

2.  An allosteric mechanism for drug block of the human cardiac potassium channel KCNQ1.

Authors:  Tao Yang; Jarrod A Smith; Brenda F Leake; Charles R Sanders; Jens Meiler; Dan M Roden
Journal:  Mol Pharmacol       Date:  2012-11-28       Impact factor: 4.436

3.  Antiarrhythmics cure brain arrhythmia: The imperativeness of subthalamic ERG K+ channels in parkinsonian discharges.

Authors:  Chen-Syuan Huang; Guan-Hsun Wang; Chun-Hwei Tai; Chun-Chang Hu; Ya-Chin Yang
Journal:  Sci Adv       Date:  2017-05-10       Impact factor: 14.136

4.  A Computational Pipeline to Predict Cardiotoxicity: From the Atom to the Rhythm.

Authors:  Pei-Chi Yang; Kevin R DeMarco; Parya Aghasafari; Mao-Tsuen Jeng; John R D Dawson; Slava Bekker; Sergei Y Noskov; Vladimir Yarov-Yarovoy; Igor Vorobyov; Colleen E Clancy
Journal:  Circ Res       Date:  2020-02-24       Impact factor: 17.367

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.